Y-Intercept (Hong Kong) Ltd - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 109 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.

Quarter-by-quarter ownership
Y-Intercept (Hong Kong) Ltd ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q4 2022$27,362
-11.7%
42,154
+68.1%
0.00%0.0%
Q2 2022$31,000
-26.2%
25,079
+100.0%
0.00%
-63.6%
Q1 2021$42,00012,5410.01%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q1 2023
NameSharesValueWeighting ↓
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 14,642,959$25,186,0003.76%
MSD Partners, L.P. 15,151,516$26,061,0002.11%
MSD Partners, L.P. 7,575,758$13,030,0001.05%
MAGNOLIA CAPITAL ADVISORS LLC 418,569$720,0000.61%
STEEL GROVE CAPITAL ADVISORS, LLC 1,080,000$1,858,0000.33%
EAM Investors, LLC 454,625$782,0000.17%
Allred Capital Management, LLC 158,000$271,0000.17%
Boxer Capital, LLC 1,500,000$2,580,0000.14%
GSA CAPITAL PARTNERS LLP 608,037$1,046,0000.14%
CHIRON CAPITAL MANAGEMENT, LLC 116,860$201,0000.14%
View complete list of ZIOPHARM ONCOLOGY INC shareholders